Please login to the form below

Not currently logged in
Email:
Password:

Patient Research

This page shows the latest Patient Research news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s Farxiga scores another FDA fast-track designation

AstraZeneca’s Farxiga scores another FDA fast-track designation

With the FDA designation in hand, AZ will be able to accelerate the research of Farxiga in this patient population. ... patient and investigator burden,” said Mene Pangalos, executive vice president, BioPharmaceuticals R&D at AZ.

Latest news

  • Key emerging trends in digital health Key emerging trends in digital health

    For the life sciences industry, tackling high dropout rates, along with encouraging patient participation in clinical research, is a top priority. ... An integral aspect of a virtual trial is its incorporation of patient-facing technologies, including

  • Chiesi launches new rare disease R&D division Chiesi launches new rare disease R&D division

    New business unit will be based in Boston, US. Italian research-focused healthcare group Chiesi has announced it will set up a new division which will advance R&D for rare ... identify opportunities for us to collaborate in research and patient

  • Pharma Brand Planners' Blog (Part 8) Pharma Brand Planners' Blog (Part 8)

    So, I’d recommend creating a straightforward, patient-based forecasting model without complex macros and hundreds of input boxes that can confuse the user and approver. ... Step 2: Collate your inputs to your forecast – current assumptions, current

  • Signant Health joins the Association of Clinical Research Organizations Signant Health joins the Association of Clinical Research Organizations

    Clinical trial solutions provider Signant Health, formerly CRF Health and Bracket, has joined the Association of Clinical Research Organizations (ACRO), a global coalition of research and technology companies. . ... As a technology provider, Signant

  • Syneos Health announces partnership with AiCure Syneos Health announces partnership with AiCure

    The partnership will see AiCure leverage Syneos’ behavioural insights-driven product development model, with the aim to capture, analyse and predict patient behaviours influencing clinical trial adherence. ... By deploying the AiCure platform to our

More from news
Approximately 0 fully matching, plus 133 partially matching documents found.

Latest Intelligence

  • Unlocking the potential of precision medicine in oncology Unlocking the potential of precision medicine in oncology

    Patient-centred research. Ultimately, I believe that precision medicine requires doing the right things, such as daring to innovate in more patient-centred research – and doing things right – by conducting research ... All of which interact in one

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    Research has shown that reframing a patient’s perspective can help foster renewed appreciation for life, inspire personal growth and motivate patients to initiate lifestyle changes, such as eating more healthily ... Looking at cancer as

  • Keep your audiences close Keep your audiences close

    Bureaucratic hurdles have made planning patient advisory boards and even meetings with patient advocacy groups more onerous than ever. ... It is based on research indicating that bystanders could help to prevent suicides by simply striking up a

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    As these plans are being developed, there are many uncertainties about what the future holds, as well as the longerterm implications on clinical research in terms of timing, patient identification and ... activities and potentially increase the risk of

  • New truths and realities in these strange times New truths and realities in these strange times

    So, what is the current PoTS patient reality in the COVID-19 world? ... This fundamental research gives unbiased and emotive patient truths that can feed new approaches to novel challenges or even some age-old problems.

More from intelligence
Approximately 0 fully matching, plus 60 partially matching documents found.

Latest appointments

  • Celerion appoints chief medical officer Celerion appoints chief medical officer

    Dr Marc Hoffman brings experience from Patient IP and Theorem Clinical Research. ... Clinical research and pharmacology service provider Celerion has appointed Dr Marc Hoffman as chief medical officer.

  • GSK appoints rare diseases research head GSK appoints rare diseases research head

    Sobi's president and CEO Geoffrey McDonough said: "We thank Birgitte for her leadership and dedication which has helped to evolve Sobi's patient oriented research and development organisation into a

  • Pfizer’s CMO joins board of Tenet Pfizer’s CMO joins board of Tenet

    In addition to her role at Pfizer Dr Lewis-Hall was appointed by the US Government to the inaugural board of governors for the Patient-Centered Outcomes Research Institute (PCORI). ... Her other industry experience includes senior roles at Vertex, Bristol

  • INC Research appoints Clare Grace INC Research appoints Clare Grace

    She joins from PPD as VP site and patient access. Contract research organisation (CRO) INC Research has appointed Dr Clare Grace as VP of site and patient access. ... In her new role, Grace will support INC Research's aim to create stronger connections

  • Sanofi appoints ‘chief patient officer’ Sanofi appoints ‘chief patient officer’

    Dr Anne Beal – a paediatrician and public health specialist - has strong experience in the field, joining Sanofi from the Patient Centered Outcomes Research Institute (PCORI) in the US, where she was ... In this role Dr Beal's responsibilities included

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Lockdown 3: Why patients cannot afford another pause in pharma-sponsored support Lockdown 3: Why patients cannot afford another pause in pharma-sponsored support

    According to a survey by the umbrella patient organization  National Voices, a third of patient groups participating in their research predicted a 40% drop in fundraising income in the period June ... Co-design intervention with panel to improve patient

  • The patient journey: A long and winding road

    In my mind, to an extent the patient journey became reduced to symptom presentation, referrals, diagnostic approaches, and, finally, treatment and prognosis. ... Porterhouse Insights is the research, insight and evidence consultancy of the Porterhouse

  • Live webinar

    Register now for this live webinar in which Research Partnership will share their approach to data storytelling with the use of a range of interactive tools and creative outputs. ... Focus on ways to elevate popular research programmes such as

  • What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health

    It is welcome to see a growing engagement with clinical research amongst the patient community. ... Co-identify and develop the most appropriate patient reported outcomes tools through all research programs.

  • What are the biggest barriers in patient recruitment? What are the biggest barriers in patient recruitment?

    With the advances that have been made in clinical research, it’s almost hard to believe that the same challenges still exist within patient recruitment. ... At the patient level, there are lots of potential barriers to participation, including:.

More from PMHub
Approximately 22 fully matching, plus 99 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics